← Back to Search

Platelet Rich Plasma

intra-ovarian platelet rich plasma injection for Female Infertility

N/A
Waitlist Available
Led By Richard T Scott, MD
Research Sponsored by Reproductive Medicine Associates of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours post egg retrieval procedure
Awards & highlights

Study Summary

This trial will study the effects of intra-ovarian injection of platelet-rich plasma (PRP) on biomarkers of ovarian reserve and IVF outcomes in women with primary ovarian insufficiency (POI) and poor ovarian response (POR).

Eligible Conditions
  • Female Infertility
  • Premature Ovarian Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours post egg retrieval procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours post egg retrieval procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
number of mature oocytes retrieved- POR group
number of participants with a mature oocyte retrieved- POI group

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Patients randomized to this group will receive the intra-ovarian platelet rich plasma injection
Group II: Control GroupActive Control1 Intervention
Patients randomized to this group will not receive the intra-ovarian platelet rich plasma injection

Find a Location

Who is running the clinical trial?

Reproductive Medicine Associates of New JerseyLead Sponsor
51 Previous Clinical Trials
37,669 Total Patients Enrolled
Richard T Scott, MDPrincipal InvestigatorReproductive Medicine Associates of New Jersey
14 Previous Clinical Trials
31,368 Total Patients Enrolled
Emre U Seli, MDPrincipal InvestigatorReproductive Medicine Associates of New Jersey
1 Previous Clinical Trials
780 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are enrollment slots available for this scientific investigation?

"Based on the clinicaltrials.gov, this medical protocol is not currently seeking participants. It was originally posted in February 2020 and last revised at the end of February 2022. Nonetheless, there are 267 other trials that are actively recruiting right now."

Answered by AI

Is the age of eligibility for participation in this trial limited to those under 35?

"Participants between 18 and 38 years old are eligible for this trial. For those younger or older than the age range, there are 20 trials specifically tailored to minors and 37 studies that cater to seniors over 65."

Answered by AI

Am I eligible to partake in this clinical trial?

"150 reproductive-age females with infertility, ranging from 18 to 38 years old, can take part in this clinical trial. In addition to the age requirement, participants must also reject egg donation treatments and display menstrual irregularities for at least 4 months."

Answered by AI

Who else is applying?

What state do they live in?
New York
California
New Jersey
Other
How old are they?
18 - 65
What site did they apply to?
Reproductive Medicine Associates of New Jersey
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I have a low ovarian reserve, and I really have to do something in order to see if I can fix this or at least maintain it enough to have a child. Please, I need help.
PatientReceived 2+ prior treatments

How responsive is this trial?

Average response time
  • < 2 Days
Typically responds via
Phone Call
Most responsive sites:
  1. Reproductive Medicine Associates of New Jersey: < 48 hours
Recent research and studies
clinicaltrials.govStudy
Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response
2020. "Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04163640.
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top